← Back to Search

Continuous Glucose Monitoring Device

Dexcom G6 CGM for Diabetes Post-TPIAT

N/A

Waitlist Available

Led By Deb Elder, MD

Research Sponsored by Deborah Elder

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

Study Summary

This trial studied how radiation affects a medical device for monitoring blood sugar levels.

Who is the study for?

This trial is for patients who are planning to undergo a Total Pancreatectomy with Islet Autotransplantation (TPIAT) at CCHMC, will stay in-patient post-surgery, and are scheduled to receive a Dexcom G6 continuous glucose monitoring device. Patients on dialysis are not eligible.Check my eligibility

What is being tested?

The study is examining how standard care radiation exposure during radiologic procedures affects the performance of the Dexcom G6 CGM device in patients undergoing TPIAT.See study design

What are the potential side effects?

Since this trial focuses on monitoring blood sugar levels using the Dexcom G6 device during standard care, side effects may be related to wearing the CGM such as skin irritation or discomfort at the sensor site.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Dexcom G6 accuracy post radiation exposure

Post radiation Dexcom G6 transmitter functional duration

Trial Design

1Treatment groups

Experimental Treatment

Group I: UncoveredExperimental Treatment1 Intervention

Dexcom G6 CGM will be uncovered during standard of care radiologic procedures.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Deborah ElderLead Sponsor

DexCom, Inc.Industry Sponsor

137 Previous Clinical Trials

29,830 Total Patients Enrolled

14 Trials studying Diabetes

3,708 Patients Enrolled for Diabetes

Deb Elder, MDPrincipal InvestigatorChildren's Hospital Medical Center, Cincinnati

Media Library

Dexcom G6 (Continuous Glucose Monitoring Device) Clinical Trial Eligibility Overview. Trial Name: NCT05607576 — N/A

Diabetes Research Study Groups: Uncovered

Diabetes Clinical Trial 2023: Dexcom G6 Highlights & Side Effects. Trial Name: NCT05607576 — N/A

Dexcom G6 (Continuous Glucose Monitoring Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05607576 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total enrollment size for this research trial?

"Affirmative. According to information on clinicaltrials.gov, this research is presently searching for additional participants. It was initially uploaded on March 1st 2022 and was last updated November 1st 2022. The medical study necessitates 40 individuals at a single site of enrolment."

Answered by AI

Are senior citizens eligible for participation in this experimental endeavor?

"For this clinical trial, the age range of inclusion is between 11 and 25 years old."

Answered by AI

Is this medical study still accepting participants?

"Affirmative. Information on clinicaltrials.gov suggests that this medical trial is actively seeking individuals for participation. It was posted on March 1st 2022 and has been updated most recently on November 1st of the same year, requiring 40 participants from one particular site."

Answered by AI

Is my participation in this clinical investigation permissible?

"This trial is searching for 40 adolescents between the ages of 11 and 25 with diabetes. Participants must also be planning to receive a TPIAT at CCHMC, remain in-patient there post procedure, as well as have access to Dexcom G6 CGM technology."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Dexcom G6 for Total Pancreatectomy With Islet Autotransplantation (TPIAT) Patients

Deborah Elder 2022. "Dexcom G6 for Total Pancreatectomy With Islet Autotransplantation (TPIAT) Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05607576.